Michael A Mussallem Edwards Lifesciences Corp (EW) insider trading activity

Michael A Mussallem is Director of Edwards Lifesciences Corp. Currently has a direct ownership of 4,485 shares of EW, which is worth approximately $320,901. The most recent transaction as insider was on Jun 09, 2021, when has been sold 32,550 shares (Common Stock) at a price of $97.23 per share, resulting in proceeds of $3,164,837. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.49K

0% 3M change

0% 12M change

Total Value Held $320,901

MICHAEL A MUSSALLEM Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 09 2021	SELL Open market or private sale	$3,164,837 $97.23 p/Share	32,550 Reduced 14.76%	188,001 Common Stock
Jun 09 2021	BUY Exercise of conversion of derivative security	$980,288 $21.76 p/Share	45,050 Added 16.2%	233,051 Common Stock
May 24 2021	SELL Open market or private sale	$3,162,720 $95.84 p/Share	33,000 Reduced 14.93%	188,001 Common Stock
May 24 2021	BUY Exercise of conversion of derivative security	$718,080 $21.76 p/Share	33,000 Added 12.99%	221,001 Common Stock
May 17 2021	BUY Exercise of conversion of derivative security	-	69,562 Added 27.01%	188,001 Common Stock
May 05 2021	SELL Bona fide gift	-	30,000 Reduced 18.7%	130,464 Common Stock
May 05 2021	SELL Open market or private sale	$3,292,641 $92.62 p/Share	35,550 Reduced 26.82%	97,014 Common Stock
May 05 2021	BUY Exercise of conversion of derivative security	$916,389 $13.98 p/Share	65,550 Added 28.74%	162,564 Common Stock
May 04 2021	BUY Grant, award, or other acquisition	-	21,425 Added 15.32%	118,439 Common Stock
Apr 27 2021	SELL Bona fide gift	-	114,205 Reduced 54.07%	97,014 Common Stock
Apr 08 2021	SELL Bona fide gift	-	30,000 Reduced 9.68%	279,770 Common Stock
Apr 08 2021	SELL Open market or private sale	$5,789,047 $84.45 p/Share	68,550 Reduced 24.5%	211,220 Common Stock
Apr 08 2021	BUY Exercise of conversion of derivative security	$1,377,729 $13.98 p/Share	98,550 Added 24.14%	309,770 Common Stock
Mar 09 2021	SELL Open market or private sale	$5,645,092 $82.35 p/Share	68,550 Reduced 24.5%	211,220 Common Stock
Mar 09 2021	SELL Bona fide gift	-	30,000 Reduced 10.7%	250,482 Common Stock
Mar 09 2021	BUY Exercise of conversion of derivative security	$1,377,729 $13.98 p/Share	98,550 Added 24.14%	309,770 Common Stock
Feb 23 2021	SELL Open market or private sale	$5,789,733 $84.46 p/Share	68,550 Reduced 22.13%	241,220 Common Stock
Feb 23 2021	SELL Bona fide gift	-	30,000 Reduced 12.44%	211,220 Common Stock
Feb 23 2021	BUY Exercise of conversion of derivative security	$1,377,729 $13.98 p/Share	98,550 Added 24.14%	309,770 Common Stock
Jan 15 2021	SELL Bona fide gift	-	30,000 Reduced 9.85%	274,462 Common Stock
Jan 15 2021	SELL Open market or private sale	$6,011,835 $87.7 p/Share	68,550 Reduced 24.5%	211,220 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$1,377,729 $13.98 p/Share	98,550 Added 24.14%	309,770 Common Stock
Dec 14 2020	SELL Bona fide gift	-	30,000 Reduced 9.69%	279,570 Common Stock
Dec 14 2020	SELL Open market or private sale	$5,819,209 $84.89 p/Share	68,550 Reduced 22.13%	241,220 Common Stock
Dec 14 2020	BUY Exercise of conversion of derivative security	$1,377,729 $13.98 p/Share	98,550 Added 24.14%	309,770 Common Stock

MAM

Michael A Mussallem

Director

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account